Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday, 13 January 2021

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

No comments:

Post a Comment

Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings

Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings : Pot Stock Canopy Growth Corporation (TSX: ...